COVID Transition Roadmap

The COVID Transition Roadmap was published in May 2024, based on the expert consensus of CTI members.

It contains thirteen recommendations for decision makers at all levels.

Read the full report:

English | Français | Italiano | Polski | Español

To protect people from the threat of endemic COVID by increasing vaccine uptake

1.      Organise regular COVID vaccination campaigns in line with national recommendations and with a particular focus on the protection of at-risk groups

2.      Communicate effectively and consistently on the importance of COVID vaccination for at-risk groups

3.      Increase convenience and diversify COVID vaccine access routes

4.      Co-administer COVID and influenza vaccines, where clinically appropriate and supported by national recommendations

5.      Empower and incentivise healthcare professionals to vaccinate against COVID

6.      Make multiple COVID vaccine technologies available

To ensure an appropriate long-term framework for routine COVID vaccination

7.      Clarify COVID vaccine strain selection timing and process

8.      Ensure procurement decisions prevent over-reliance on one COVID vaccine product

9.      Encourage research and innovation into new tools against COVID

10. Review and strengthen healthcare professional training on vaccination

To drive progress in COVID vaccination year-on-year

11. Maintain timely data monitoring and reporting on key indicators for COVID

12. Take proactive measures to address Long COVID, protect at-risk groups and minimise incidence

13. Set a 75% COVID vaccine uptake target, like for influenza

The drafting of the COVID Transition Roadmap was carried out by the secretariat of the CTI, Fourtold. Its content summarises discussions that took place during April and May 2024 among CTI members.